NCT05786027

Brief Summary

The purpose of this study is to develop, conduct, and assess the feasibility of a) a pilot peer-driven intervention (PDI) to reduce HIV risk and increase the uptake of primary HIV prevention services (i.e. prison addiction treatment programs), and b) explore the PDI's usefulness from the perspective of both prisoners and prison staff to make recommendations for the PDI future improvement and adaptation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P25-P50 for not_applicable hiv

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

March 14, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 27, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

February 15, 2024

Status Verified

February 1, 2024

Enrollment Period

1.7 years

First QC Date

March 14, 2023

Last Update Submit

February 13, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of participants enrolled in MMT or Atlantis 12-step addiction recovery program

    Number of participants that enrolled in MMT or Atlantis 12-step addiction recovery program from baseline up to 12 weeks.

    up to 12 weeks

  • Number of participants enrolled in MMT or Atlantis 12-step addiction recovery program

    Number of participants that enrolled in MMT or Atlantis 12-step addiction recovery program at month 9.

    Month 9

Secondary Outcomes (2)

  • Number of times participants relapsed

    Month 6

  • Number of times participants relapsed

    Month 9

Study Arms (2)

Peer Driven Intervention (PDI)

EXPERIMENTAL

Participants from two experimental (E) prisons that are HIV-negative will be assigned to this arm. Participants will receive 12 weeks of PDI and weekly opioid urine tests. Prior to intervention participants will receive training by a Health Educator (HE) in Health Advocate (HA) and Peer roles.

Behavioral: PDI

Treatment As Usual (TAU)

NO INTERVENTION

Participants from two control (C) prisons that are HIV-negative will be assigned to this arm. Participants will receive treatment as usual (which includes universal access to SSP, MMT, and Atlantis program for individuals with opioid dependence) and weekly urine opioid tests for 12 weeks.

Interventions

PDIBEHAVIORAL

A 12-week in-prison peer-driven intervention to increase the uptake of primary HIV prevention strategies (readiness to initiate addiction treatment (MMT or Atlantis), initiation of MMT/Atlantis, retention in MMT/Atlantis; or the use of SSP), and reduce the use of opioids and HIV risk behaviors, in HIV-negative PWID in prison.

Peer Driven Intervention (PDI)

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsThere is only one female prison in KYR and few women PWID in prison (about 1% of the total female prisoner population) per our recent bio-behavioral study. Thus, only men will be included into the pilot PDI in this instance.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV negative by self-report before the study confirmed by HIV rapid test
  • Has ever injected drugs
  • ≥1 year before prison release (release dates are fixed and accurate)
  • currently not enrolled in MMT/Atlantis
  • Capable of providing informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prison System

Bishkek, 720051, Kyrgyzstan

Location

Study Officials

  • Julia Rozanova, PhD

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2023

First Posted

March 27, 2023

Study Start

January 1, 2022

Primary Completion

August 31, 2023

Study Completion

August 31, 2023

Last Updated

February 15, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations